These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26525105)

  • 21. The tumor suppressive microRNA miR-218 targets the mTOR component Rictor and inhibits AKT phosphorylation in oral cancer.
    Uesugi A; Kozaki K; Tsuruta T; Furuta M; Morita K; Imoto I; Omura K; Inazawa J
    Cancer Res; 2011 Sep; 71(17):5765-78. PubMed ID: 21795477
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
    Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
    Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic microRNA markers to screen for sporadic human colon cancer in stool: I. Proof of principle.
    Ahmed FE; Ahmed NC; Vos PW; Bonnerup C; Atkins JN; Casey M; Nuovo GJ; Naziri W; Wiley JE; Mota H; Allison RR
    Cancer Genomics Proteomics; 2013; 10(3):93-113. PubMed ID: 23741026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Programmed cell death 4 nuclear loss and miR-21 or activated Akt overexpression in esophageal squamous cell carcinogenesis.
    Fassan M; Realdon S; Pizzi M; Balistreri M; Battaglia G; Zaninotto G; Ancona E; Rugge M
    Dis Esophagus; 2012 Apr; 25(3):263-8. PubMed ID: 21883657
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential of tumor-suppressive miR-596 targeting LGALS3BP as a therapeutic agent in oral cancer.
    Endo H; Muramatsu T; Furuta M; Uzawa N; Pimkhaokham A; Amagasa T; Inazawa J; Kozaki K
    Carcinogenesis; 2013 Mar; 34(3):560-9. PubMed ID: 23233740
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oncogenic microRNAs as biomarkers of oral tumorigenesis and minimal residual disease.
    Santhi WS; Prathibha R; Charles S; Anurup KG; Reshmi G; Ramachandran S; Jissa VT; Sebastian P; Radhakrishna Pillai M
    Oral Oncol; 2013 Jun; 49(6):567-75. PubMed ID: 23380617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-494 represses HOXA10 expression and inhibits cell proliferation in oral cancer.
    Libório-Kimura TN; Jung HM; Chan EK
    Oral Oncol; 2015 Feb; 51(2):151-7. PubMed ID: 25500095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Establishment of syngeneic murine model for oral cancer therapy.
    Chen YF; Chang KW; Yang IT; Tu HF; Lin SC
    Oral Oncol; 2019 Aug; 95():194-201. PubMed ID: 31345390
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Abberent expression of oncogenic and tumor-suppressive microRNAs and their target genes in human adenocarcinoma alveolar basal epithelial cells.
    Tafsiri E; Darbouy M; Shadmehr MB; Cho WC; Karimipoor M
    J Cancer Res Ther; 2016; 12(1):395-400. PubMed ID: 27072269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of global microRNA expression in splenic marginal zone lymphoma and influence of chronic hepatitis C virus infection.
    Peveling-Oberhag J; Crisman G; Schmidt A; Döring C; Lucioni M; Arcaini L; Rattotti S; Hartmann S; Piiper A; Hofmann WP; Paulli M; Küppers R; Zeuzem S; Hansmann ML
    Leukemia; 2012 Jul; 26(7):1654-62. PubMed ID: 22307176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Homeobox C5 expression is associated with the progression of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis.
    Moon SM; Ahn MY; Kwon SM; Kim SA; Ahn SG; Yoon JH
    J Oral Pathol Med; 2012 Jul; 41(6):470-6. PubMed ID: 22385119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. COX-2 Elevates Oncogenic miR-526b in Breast Cancer by EP4 Activation.
    Majumder M; Landman E; Liu L; Hess D; Lala PK
    Mol Cancer Res; 2015 Jun; 13(6):1022-33. PubMed ID: 25733698
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comprehensive search for microRNAs with expression profiles modulated by oncogenic KRAS: potential involvement of miR-31 in lung carcinogenesis.
    Okudela K; Suzuki T; Umeda S; Tateishi Y; Mitsui H; Miyagi Y; Ohashi K
    Oncol Rep; 2014 Oct; 32(4):1374-84. PubMed ID: 25050641
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGFR promotes lung tumorigenesis by activating miR-7 through a Ras/ERK/Myc pathway that targets the Ets2 transcriptional repressor ERF.
    Chou YT; Lin HH; Lien YC; Wang YH; Hong CF; Kao YR; Lin SC; Chang YC; Lin SY; Chen SJ; Chen HC; Yeh SD; Wu CW
    Cancer Res; 2010 Nov; 70(21):8822-31. PubMed ID: 20978205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide.
    Ribeiro DA; Salvadori DM; Marques ME
    Int J Exp Pathol; 2005 Dec; 86(6):375-81. PubMed ID: 16309543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral mucosal carcinogenesis in SENCAR mice.
    Kim TW; Chen Q; Shen X; Regezi JA; Ramos DM; Tanaka H; Jordan RC; Kramer RH
    Anticancer Res; 2002; 22(5):2733-40. PubMed ID: 12529989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
    Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
    BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma.
    Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H
    Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection.
    Park NJ; Zhou H; Elashoff D; Henson BS; Kastratovic DA; Abemayor E; Wong DT
    Clin Cancer Res; 2009 Sep; 15(17):5473-7. PubMed ID: 19706812
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene expression profiling signatures for the diagnosis and prevention of oral cavity carcinogenesis-genome-wide analysis using RNA-seq technology.
    Tang XH; Urvalek AM; Osei-Sarfo K; Zhang T; Scognamiglio T; Gudas LJ
    Oncotarget; 2015 Sep; 6(27):24424-35. PubMed ID: 26110572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.